"Atención de calidad con calidez humana; al mejor costo"

During the past decade, Centro Hemato Oncológico Privado conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Hemato Oncológico Privado" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centro Hemato Oncológico Privado" are "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Endometrial Neoplasms" (1 trials). Many other conditions were trialed in "Centro Hemato Oncológico Privado" in a lesser frequency.

Most popular intervention types in "Centro Hemato Oncológico Privado" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Avastin" (1 trials), "BI 695502" (1 trials), "Doxorubicin" (1 trials), "Lenvatinib" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Hemato Oncológico Privado" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centro Hemato Oncológico Privado". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro Hemato Oncológico Privado, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Hemato Oncológico Privado, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".